Ivan Kairatov is a seasoned biopharma expert whose career has been defined by a deep commitment to unraveling the complexities of tech-driven innovation within the life sciences. With extensive experience in research and development, he has spent years bridging the gap between molecular discovery
The human body possesses a hidden archival system that documents every trauma, infection, and inflammatory surge at a molecular level, far below the reach of standard clinical imaging. While a patient might receive a clean bill of health after a bout of chronic inflammation, their cellular "hard
The pharmaceutical landscape is currently witnessing a high-stakes transition as major developers scramble to identify the next generation of blockbuster treatments for atopic dermatitis. With the clock ticking on existing patents, the industry is closely monitoring whether innovative mechanisms
Ivan Kairatov is a seasoned biopharma expert with an extensive background in research and development, specializing in the intersection of technology and clinical innovation. With years of experience navigating the complexities of the drug approval pipeline, he has become a leading voice on how
The pharmaceutical industry is currently witnessing a transformative shift in drug development as researchers move beyond the limitations of traditional small-molecule inhibitors toward the sophisticated field of Targeted Protein Degradation. While conventional therapies often focus on blocking the
The silent accumulation of arterial plaque often begins decades before a patient ever experiences a single symptom or steps into a cardiologist’s office for a formal consultation. For years, the medical community operated under a reactive framework, waiting for risk factors to solidify in middle
